Cannabix Technologies to Beta Test Marijuana Breathalyzer With Private Clinic
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, will begin beta testing its THC Breath Analyzer with a private drug-testing clinic located in the Northwestern United States. Cannabix expects to deliver its version 3.0 THCBA prototype to this clinic in the coming weeks to begin breath testing with select patients.
The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state. Beta-testing of the THC Breath Analyzer prototype will focus on training the device’s machine learning database, to help determine sensitivity ranges and improving user and administrator experience. Furthermore, this data will help with identifying cross-reactivity of other substances with the study population. The THC Breath Analyzer is a drug screening device for employers and other markets who are seeking a way to quickly, easily, and non-invasively test for recent use of D9-tetrahydrocannabinol — the psychoactive component of marijuana that causes impairment.
Read more about Cannabix Technologies to Beta Test Marijuana Breathalyzer With Private Clinic in Northwestern U.S.